American Heart Journal
Volume 158, Issue 2 , Pages 177-184, August 2009

Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study

  • Ludovic Drouet, MD, PhD

      Affiliations

    • Department of Angio-Hematology, Hôpital Lariboisière, AP-HP Paris, France
    • University of Paris VII-Denis Diderot, Paris, France
    • Corresponding Author InformationReprint requests: Ludovic Drouet, MD, PhD, Angio-Hematology Department, Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris cedex 10, Paris, France.
    • ,
  • Claire Bal dit Sollier, MB

      Affiliations

    • Experimental Thrombosis and Atherosclerosis Laboratory, Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France
    • ,
  • Jack Martin, MD

      Affiliations

    • Sharpe-Strumia Research Foundation of the Bryn Mawr Hospital, Bryn Mawr, PA

Received 29 January 2009; accepted 18 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Randomized clinical trial no.: NCT00622115.

 Prof Drouet reports receiving grant support from sanofi-aventis, Eli Lilly, and GSK, and consulting and lecture fees from sanofi-aventis, BMS, AstraZeneca, The Medicine Company, GSK, Servier, Cordis and Boehringer-Ingelheim. Dr Bal dit Sollier reports being an employee of the Blood and Vessel Institute and receiving grant support from sanofi-aventis and Eli Lilly. Dr Martin reports receiving consulting and lecture fees from sanofi-aventis.

PII: S0002-8703(09)00386-X

doi:10.1016/j.ahj.2009.05.022

American Heart Journal
Volume 158, Issue 2 , Pages 177-184, August 2009

Article Tools

* Image Usage & Resolution